* Use coupon code PODCAST25 for 25% off this webcast *

https://www.theknowledgegroup.org/webcasts/obviousness-type-double-patenting/

Join us for this Knowledge Group Online CLE Double Patenting Webinar. The emergence of new court rulings in the U.S. and Canada continues to shape the applicability and scope of the obviousness-type double patenting (ODP) doctrine, which is meant to prevent patentees from unjustly extending patent rights by owning multiple patents on the same invention. Recently, the U.S. Court of Appeals for the Federal Circuit issued two significant decisions - Novartis AG v. Ezra Ventures LLC and Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical Inc. - which provide guidance on when ODP does not invalidate patent term extensions (PTEs). In Canada, where there is no terminal disclaimer, upcoming changes to the Patent Rules will impact procedures commonly used to prevent double patenting.

Counsel to patent applicants and owners should be in the know of the recent court rulings and other developments involving ODP to better manage potential threats and opportunities regarding patent term and validity.

This Webcast produced by The Knowledge Group will provide patent practitioners with an in-depth analysis of the evolving ODP landscape in the USA and Canada. They will examine the implications of recent U.S. Court rulings in Ezra and Breckenridge and other ODP updates while offering insights on how to best protect a client’s interests from significant ODP issues in the U.S. and Canada.

For any more information please click on the webcast URL at the top of this description.